← Eichor
Study identifier: NCT06770634 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Investigation of Central Sensitization and Associated Factors in Patients With Lipedema

Condition: Lipedema · Central Sensitisation  ·  Sponsor: Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

PhaseN/A
Planned participants50
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

This study aims to investigate the presence of central sensitization and its associated parameters in patients with lipedema. Lipedema is a chronic and hereditary condition that primarily affects the lower extremities in women and is often associated with hormonal changes. Symptoms such as pain, swelling, and tenderness are common in lipedema, and these symptoms may be related to central sensitization. Additionally, the ultrasonographic findings and pain sensitivity in lipedema will be compared with those of healthy individuals. This study seeks to contribute to the diagnosis and treatment process of lipedema.

This description comes directly from the study's public registry record.

Talk to the study team

Zeynep Candan, MD  ·  drzeynepcandan@gmail.com  ·  drzeynepcandan@gmail.com

Feyza N Yucel, MD

Always discuss trial participation with your own doctor first.

Locations (1)

Sultan 2. Abdülhamid Han Eğitim ve Araştırma Hastanesi, İstanbul, Üsküdar 34000Istanbul, Üsküdar, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06770634